Correlation Between Fusion Pharmaceuticals and 908 Devices
Can any of the company-specific risk be diversified away by investing in both Fusion Pharmaceuticals and 908 Devices at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fusion Pharmaceuticals and 908 Devices into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fusion Pharmaceuticals and 908 Devices, you can compare the effects of market volatilities on Fusion Pharmaceuticals and 908 Devices and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fusion Pharmaceuticals with a short position of 908 Devices. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fusion Pharmaceuticals and 908 Devices.
Diversification Opportunities for Fusion Pharmaceuticals and 908 Devices
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Fusion and 908 is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Fusion Pharmaceuticals and 908 Devices in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 908 Devices and Fusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fusion Pharmaceuticals are associated (or correlated) with 908 Devices. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 908 Devices has no effect on the direction of Fusion Pharmaceuticals i.e., Fusion Pharmaceuticals and 908 Devices go up and down completely randomly.
Pair Corralation between Fusion Pharmaceuticals and 908 Devices
Given the investment horizon of 90 days Fusion Pharmaceuticals is expected to under-perform the 908 Devices. But the stock apears to be less risky and, when comparing its historical volatility, Fusion Pharmaceuticals is 1.27 times less risky than 908 Devices. The stock trades about -0.05 of its potential returns per unit of risk. The 908 Devices is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 714.00 in 908 Devices on August 30, 2024 and sell it today you would lose (452.00) from holding 908 Devices or give up 63.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 13.71% |
| Values | Daily Returns |
Fusion Pharmaceuticals vs. 908 Devices
Performance |
| Timeline |
| Fusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| 908 Devices |
Fusion Pharmaceuticals and 908 Devices Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fusion Pharmaceuticals and 908 Devices
The main advantage of trading using opposite Fusion Pharmaceuticals and 908 Devices positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fusion Pharmaceuticals position performs unexpectedly, 908 Devices can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 908 Devices will offset losses from the drop in 908 Devices' long position.| Fusion Pharmaceuticals vs. Bicycle Therapeutics | Fusion Pharmaceuticals vs. Relmada Therapeutics | Fusion Pharmaceuticals vs. RAPT Therapeutics | Fusion Pharmaceuticals vs. NewAmsterdam Pharma |
| 908 Devices vs. Inari Medical | 908 Devices vs. CONMED | 908 Devices vs. Glaukos Corp | 908 Devices vs. Nevro Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |